Global Markets Edge Higher as USIran Talks Offer Fragile Calm Oil Stays Above 100 Federal Cannabis Rescheduling Could Lift Tax Burden Potentially Unlocking Billions for Industry Markets Record Run Boosts Portfolio Top and Bottom Performers Over Six Weeks Ouster Stock Surges Following Drone Interceptor Partnership Announcement BP Shares Decline as Board Removes Chairman Albert Manifold Over Serious Conduct Concerns 15 Cities with the Worlds Best Public Transit Economic and Investment Implications LMFA Q1 2026 Earnings WiderthanExpected Loss Drags on Bitcoin Mining Results Insulet Corporation PODD Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Pullback SERV Q1 2026 Earnings WiderThanExpected Loss Amid EarlyStage Robotics Progress PACB Q1 2026 Earnings Narrowerthanexpected loss drives positive market reaction VRRM Q1 2026 Earnings EPS Beats Estimates on Strong Execution Stock Slightly Higher Spire Inc SR Q1 2026 Earnings Beat EPS Estimates with Positive Surprise Strategy Inc Preferred Stock STRC Sees Marginal Decline Amid Tight Trading Range ADAMH Edges Higher Adamas Trust Senior Notes Hold Steady Near Par 1stdibscom Inc DIBS Tests Support Zone After Recent Uptick Calamos Strategic Total Return CSQ Rises 069 to 2047 Approaching Key Resistance at 2149 Allegiant Travel ALGT Surges 86 as Value Airline Rebounds Sharply Rising Dragon Acquisition Corp Rights RDACR Decline 833 as Stock Nears Support Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback Procter Gamble PG Holds Steady Modest Gain Amidst Staples Sector Resilience Marathon Petroleum MPC Rallies 25 as Energy Sector Gains Momentum ArtsWay Manufacturing Co Inc ARTW Faces Pressure Tests Key Support Level Boston Omaha BOC Gains 176 as Shares Test Key Resistance at 1339 Arista Networks Faces PostEarnings SellOff Amid Heightened AI Market Expectations Kilroy Realty Q1 2026 Earnings Significant EPS Miss as Office Market Challenges Persist VS Media Holdings VSME Surges 29 Testing Key Resistance at 110 RDHL Q2 2022 Earnings Massive EPS Miss Despite No Revenue Stock Rises 481 GPN Q1 2026 Earnings EPS Beats Estimates by 366 as Stock Edges Higher GWW Q1 2026 Earnings Earnings per Share Surpass Estimates by Nearly 13 Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline GOODO Q1 2026 Earnings Preferred Stock Rises as EPS Surges Past Estimates CBRE Q1 2026 Earnings Massive EPS Beat Masks Tepid Market Reception